Characterization of the prototype foamy virus envelope glycoprotein receptor-binding domain

Journal of Virology

Volumn 80, Issue 16, 2006, Pages 8158-8167

  Duda, Anja ^a   Lüftenegger, Daniel ^a   Pietschmann, Thomas ^b,c   Lindemann, Dirk ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYSTEINE; ENVELOPE PROTEIN; GLYCOPROTEIN GP 130; IMMUNOADHESIN; PROTEIN PRECURSOR; PROTEIN SUBUNIT; RECEPTOR; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EMBRYO; FLOW CYTOMETRY; GENE DELETION; GLYCOSYLATION; HUMAN; HUMAN CELL; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RECEPTOR BINDING; SPUMA VIRUS; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS PARTICLE;

AMINO ACID MOTIFS; ANIMALS; BINDING SITES; CRICETINAE; DNA MUTATIONAL ANALYSIS; DOGS; GENE PRODUCTS, ENV; GLYCOSYLATION; HUMANS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, VIRUS; SEQUENCE DELETION; SPUMAVIRUS;

HUMAN SPUMARETROVIRUS;

EID: 33746793602     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00460-06     Document Type: Article

References (42)

1. Bansal, A., K. L. Shaw, B. H. Edwards, P. A. Goepfert, and M. J. Mulligan. 2000. Characterization of the R572T point mutant of a putative cleavage site in human foamy virus Env. J. Virol. 74:2949-2954.
2. Battini, J. L., O. Danos, and J. M. Heard. 1995. Receptor-binding domain of murine leukemia virus envelope glycoproteins. J. Virol. 69:713-719.
3. Battini, J. L., S. C. Kayman, A. Pinter, J. M. Heard, and O. Danos. 1994. Role of N-linked glycosylation in the activity of the Friend murine leukemia virus SU protein receptor-binding domain. Virology 202:496-499.
4. Berg, A., T. Pietschmann, A. Rethwilm, and D. Lindemann. 2003. Determinants of foamy virus envelope glycoprotein mediated resistance to superinfection. Virology 314:243-252.
5. Crandell, R. A., C. G. Fabricant, and W. A. Nelson-Rees. 1973. Development, characterization, and viral susceptibility of a feline (Felis catus) renal cell line (CRFK). In Vitro 9:176-185.
6. Davey, R. A., C. A. Hamson, J. J. Healey, and J. M. Cunningham. 1997. In vitro binding of purified murine ecotropic retrovirus envelope surface protein to its receptor, MCAT-1. J. Virol. 71:8096-8102.
7. Dimitrov, D. S. 2004. Virus entry: molecular mechanisms and biomedical applications. Nat. Rev. Microbiol. 2:109-122.
8. Dinev, D., B. W. Jordan, B. Neufeld, J. D. Lee, D. Lindemann, U. R. Rapp, and S. Ludwig. 2001. Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cells. EMBO Rep. 2:829-834.
9. Du Bridge, R. B., P. Tang, H. C. Hsia, P. M. Leong, J. H. Miller, and M. P. Calos. 1987. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7:379-387.
10. Duda, A., A. Stange, D. Lüftenegger, N. Stanke, D. Westphal, T. Pietschmann, S. W. Eastman, M. L. Linial, A. Rethwilm, and D. Lindemann. 2004. Prototype foamy virus envelope glycoprotein leader peptide processing is mediated by a furin-like cellular protease, but cleavage is not essential for viral infectivity. J. Virol. 78:13865-13870.
11. Geiselhart, V., P. Bastone, T. Kempf, M. Schnolzer, and M. Löchelt. 2004. Furin-mediated cleavage of the feline foamy virus Env leader protein. J. Virol. 78:13573-13581.
12. Geiselhart, V., A. Schwantes, P. Bastone, M. Frech, and M. Löchelt. 2003. Features of the Env leader protein and the N-terminal Gag domain of feline foamy virus important for virus morphogenesis. Virology 310:235-244.
13. Heard, J. M., and O. Danos. 1991. An amino-terminal fragment of the Friend murine leukemia virus envelope glycoprotein binds the ecotropic receptor. J. Virol. 65:4026-4032.
14. Herchenröder, O., D. Moosmayer, M. Bock, T. Pietschmann, A. Rethwilm, P. D. Bieniasz, M. O. McClure, R. Weis, and J. Schneider. 1999. Specific binding of recombinant foamy virus envelope protein to host cells correlates with susceptibility to infection. Virology 255:228-236.
15. Higuchi, R. 1990. Recombinant PCR, p. 177-183. In M. A. Innis, D. H. Gelfand, and T. J. White (ed.), PCR protocols: a guide to methods and applications. Academic Press, San Diego, Calif.
16. Hill, C. L., P. D. Bieniasz, and M. O. McClure. 1999. Properties of human foamy virus relevant to its development as a vector for gene therapy. J. Gen. Virol. 80:2003-2009.
17. Hooks, J. J., and C. J. Gibbs, Jr. 1975. The foamy viruses. Bacteriol. Rev. 39:169-185.
18. Josephson, N. C., G. Trobridge, and D. W. Russell. 2004. Transduction of long-term and mobilized peripheral blood-derived NOD/SCID repopulating cells by foamy virus vectors. Hum. Gene Ther. 15:87-92.
19. Josephson, N. C., G. Vassilopoulos, G. D. Trobridge, G. V. Priestley, B. L. Wood, T. Papayannopoulou, and D. W. Russell. 2002. Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors. Proc. Natl. Acad. Sci. USA 99:8295-8300.
20. Kowalski, M., J. Potz, L. Basiripour, T. Dorfman, W. C. Goh, E. Terwilliger, A. Dayton, C. Rosen, W. Haseltine, and J. Sodroski. 1987. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237:1351-1355.
21. Leonard, C. K., M. W. Spellman, L. Riddle, R. J. Harris, J. N. Thomas, and T. J. Gregory. 1990. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 265:10373-10382.
22. Leurs, C., M. Jansen, K. E. Pollok, M. Heinkelein, M. Schmidt, M. Wissler, D. Lindemann, C. Von Kalle, A. Rethwilm, D. A. Williams, and H. Hanenberg. 2003. Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34(+) cord blood cells. Hum. Gene Ther. 14:509-519.
23. Lindemann, D., M. Bock, M. Schweizer, and A. Rethwilm. 1997. Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins. J. Virol. 71:4815-4820.
24. Lindemann, D., and P. A. Goepfert. 2003. The foamy virus envelope glycoproteins. Curr. Top. Microbiol. Immunol. 277:111-129.
25. Lindemann, D., T. Pietschmann, M. Picard-Maureau, A. Berg, M. Heinkelein, J. Thurow, P. Knaus, H. Zentgraf, and A. Rethwilm. 2001. A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity. J. Virol. 75:5762-5771.
26. Linder, M., D. Linder, J. Hahnen, H. H. Schott, and S. Stirm. 1992. Localization of the intrachain disulfide bonds of the envelope glycoprotein 71 from Friend murine leukemia virus. Eur. J. Biochem. 203:65-73.
27. Linder, M., V. Wenzel, D. Linder, and S. Stirm. 1994. Structural elements in glycoprotein 70 from polytropic Friend mink cell focus-inducing virus and glycoprotein 71 from ecotropic Friend murine leukemia virus, as defined by disulfide-bonding pattern and limited proteolysis. J. Virol. 68:5133-5141.
28. Lüftenegger, D., M. Picard-Maureau, N. Stanke, A. Rethwilm, and D. Lindemann. 2005. Analysis and function of prototype foamy virus envelope N glycosylation. J. Virol. 79:7664-7672.
29. MacKrell, A. J., N. W. Soong, C. M. Curtis, and W. F. Anderson. 1996. Identification of a subdomain in the Moloney murine leukemia virus envelope protein involved in receptor binding. J. Virol. 70:1768-1774.
30. Macpherson, I., and M. Stoker. 1962. Polyoma transformation of hamster cell clones-an investigation of genetic factors affecting cell competence. Virology 16:147-151.
31. McClure, M. O., and O. Erlwein. 1995. Foamy viruses-pathogenic or therapeutic potential? Rev. Med. Virol. 5:229-237.
32. Mergia, A., and M. Heinkelein. 2003. Foamy virus vectors. Curr. Top. Microbiol. Immunol. 277:131-159.
33. Nelson-Rees, W. A., R. B. Owens, P. Arnstein, and A. J. Kniazeff. 1976. Source, alterations, characteristics and use of a new dog cell line (Cf2Th). In Vitro 12:665-669.
34. Nygren, A., T. Bergman, T. Matthews, H. Jornvall, and H. Wigzell. 1988. 95- and 25-kDa fragments of the human immunodeficiency virus envelope glycoprotein gp120 bind to the CD4 receptor. Proc. Natl. Acad. Sci. USA 85:6543-6546.
35. Picard-Maureau, M., G. Jarmy, A. Berg, A. Rethwilm, and D. Lindemann. 2003. Foamy virus envelope glycoprotein-mediated entry involves a pH-dependent fusion process. J. Virol. 77:4722-4730.
36. Pietschmann, T., H. Zentgraf, A. Rethwilm, and D. Lindemann. 2000. An evolutionarily conserved positively charged amino acid in the putative membrane-spanning domain of the foamy virus envelope protein controls fusion activity. J. Virol. 74:4474-4482.
37. Rasheed, S., W. A. Nelson-Rees, E. M. Toth, P. Arnstein, and M. B. Gardner. 1974. Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer 33:1027-1033.
38. Rethwilm, A. 2003. The replication strategy of foamy viruses. Curr. Top. Microbiol. Immunol. 277:1-26.
39. Riggs, J. L., R. M. McAllister, and E. H. Lennette. 1974. Immunofluorescent studies of RD-114 virus replication in cell culture. J. Gen. Virol. 25:21-29.
40. Stanke, N., A. Stange, D. Lüftenegger, H. Zentgraf, and D. Lindemann. 2005. Ubiquitination of the prototype foamy virus envelope glycoprotein leader peptide regulates subviral particle release. J. Virol. 79:15074-15083.
41. Wilk, T., F. de Haas, A. Wagner, T. Rutten, S. Fuller, R. M. Flügel, and M. Löchelt. 2000. The intact retroviral Env glycoprotein of human foamy virus is a trimer. J. Virol. 74:2885-2887.
42. Wilk, T., V. Geiselhart, M. Frech, S. D. Fuller, R. M. Flügel, and M. Löchelt. 2001. Specific interaction of a novel foamy virus Env leader protein with the N-terminal Gag domain. J. Virol. 75:7995-8007.